Generate Biomedicines, Inc. (GENB)
14.34
+0.36
(+2.54%)
USD |
NASDAQ |
Oct 09, 16:00
14.34
0.00 (0.00%)
After-Hours: 19:35
Generate Biomedicines Price to Book Value : 4.035 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.935 |
| October 07, 2026 | 3.817 |
| October 06, 2026 | 3.882 |
| October 05, 2026 | 3.912 |
| October 02, 2026 | 3.850 |
| October 01, 2026 | 3.882 |
| September 30, 2026 | 4.225 |
| September 29, 2026 | 4.337 |
| September 28, 2026 | 4.194 |
| September 25, 2026 | 4.261 |
| September 24, 2026 | 4.497 |
| September 23, 2026 | 4.646 |
| September 22, 2026 | 4.911 |
| September 21, 2026 | 4.888 |
| September 18, 2026 | 4.821 |
| September 17, 2026 | 4.815 |
| September 16, 2026 | 4.410 |
| September 15, 2026 | 4.554 |
| September 14, 2026 | 4.500 |
| September 11, 2026 | 4.422 |
| September 10, 2026 | 4.329 |
| September 09, 2026 | 4.365 |
| September 08, 2026 | 4.472 |
| September 04, 2026 | 4.610 |
| September 03, 2026 | 4.596 |
| Date | Value |
|---|---|
| September 02, 2026 | 4.579 |
| September 01, 2026 | 4.441 |
| August 31, 2026 | 4.295 |
| August 28, 2026 | 4.312 |
| August 27, 2026 | 4.436 |
| August 26, 2026 | 4.540 |
| August 25, 2026 | 5.732 |
| August 24, 2026 | 4.984 |
| August 21, 2026 | 4.534 |
| August 20, 2026 | 4.497 |
| August 19, 2026 | 4.773 |
| August 18, 2026 | 4.523 |
| August 17, 2026 | 4.413 |
| August 14, 2026 | 4.399 |
| August 13, 2026 | 4.227 |
| August 12, 2026 | 4.244 |
| August 11, 2026 | 4.014 |
| August 10, 2026 | 4.140 |
| August 07, 2026 | 4.036 |
| August 06, 2026 | 3.907 |
| August 05, 2026 | 4.076 |
| August 04, 2026 | 4.016 |
| August 03, 2026 | 4.033 |
| July 31, 2026 | 3.938 |
| July 30, 2026 | 3.946 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 22.47 |
| Intellia Therapeutics, Inc. | 2.517 |
| Prime Medicine, Inc. | 18.14 |
| Beam Therapeutics, Inc. | 2.488 |
| Moderna, Inc. | 13.25 |
Price to Book Value Related Metrics
| PS Ratio | 35.60 |
| Price | 14.34 |
| Earnings Yield | -32.20% |
| Market Cap | 1.840B |